NDC product
LIQUID · AbbVie Inc.
NDC 0074-1059 · AbbVie Inc.
Key facts
| Product NDC | 0074-1059 |
|---|---|
| Nonproprietary name | Risankizumab |
| Substances | RISANKIZUMAB |
| Dosage form | LIQUID |
| Labeler | AbbVie Inc. |
| Product type | BULK INGREDIENT |
| Marketing category | BULK INGREDIENT |
| Marketing start | Apr 17, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: